The Corporation Posts Quarterly Records for Key Financial Metrics including Revenue of $710 million, Adjusted EBITDA1 of $193 ...
This is the first commercially available small particle detector on a cell sorter and offers a significant advancement for rapidly evolving research fields, including in drug delivery, cell therapy, ...